Literature DB >> 18784827

Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall.

Shiyong Li1, Karen P Mann, Jeannine T Holden.   

Abstract

Reported herein is a case of composite small lymphocytic lymphoma (SLL) and extramedullary myeloid tumor (EMT) occurring in the same lymph node. Routine morphologic examination revealed a diffuse proliferation of small mature lymphocytes with numerous irregularly dispersed nodules, closely resembling SLL with prominent proliferation centers or Richter's transformation. Flow cytometric immunophenotyping and immunohistochemical stains demonstrated the presence of SLL cells as well as myeloblasts, confirming the diagnosis of a composite SLL and EMT. Conventional cytogenetics and fluorescence in situ hybridization studies revealed inversion 16 chromosome involving the core binding factor beta and myosin heavy chain 11 genes, characteristic of acute myeloid leukemia with abnormal bone marrow eosinophils and inv(16) or t(16;16) [CBFbeta/MYH11]. In conclusion, the occurrence of SLL and EMT in the same lymph node is rare and multiparameter approach is essential for a definitive diagnosis.

Entities:  

Keywords:  Extramedullary myeloid tumor; flow cytometric immunophenotyping; fluorescence in situ hybridization; immunohistochemistry; karyotype; small lymphocytic lymphoma

Year:  2008        PMID: 18784827      PMCID: PMC2480536     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

Authors:  Terry J Hamblin; Jenny A Orchard; Rachel E Ibbotson; Zadie Davis; Peter W Thomas; Freda K Stevenson; David G Oscier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

2.  Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry.

Authors:  Jonathan Juco; Jeannine T Holden; Karen P Mann; Lloyd G Kelley; Shiyong Li
Journal:  Am J Clin Pathol       Date:  2003-02       Impact factor: 2.493

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases.

Authors:  L P Menasce; S S Banerjee; E Beckett; M Harris
Journal:  Histopathology       Date:  1999-05       Impact factor: 5.087

5.  Myeloid sarcoma involving the testis.

Authors:  Jose R Valbuena; Joan H Admirand; Pei Lin; L Jeffrey Medeiros
Journal:  Am J Clin Pathol       Date:  2005-09       Impact factor: 2.493

6.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Authors:  Apostolia-Maria Tsimberidou; Susan O'Brien; Issa Khouri; Francis J Giles; Hagop M Kantarjian; Richard Champlin; Sijin Wen; Kim-Anh Do; Susan C Smith; Susan Lerner; Emil J Freireich; Michael J Keating
Journal:  J Clin Oncol       Date:  2006-05-20       Impact factor: 44.544

Review 8.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating
Journal:  Semin Oncol       Date:  2006-04       Impact factor: 4.929

9.  Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases.

Authors:  S T Traweek; D A Arber; H Rappaport; R K Brynes
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

10.  The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.

Authors:  I Hus; M Podhorecka; A Bojarska-Junak; J Roliński; M Schmitt; M Sieklucka; E Wasik-Szczepanek; A Dmoszyńska
Journal:  Ann Oncol       Date:  2006-03-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.